Showing results (1731-1740 of 8,886) with videos related to

Sort By:
Pageof 889
European Urology|September 6, 2024
Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION TrialAndrew J Armstrong, Oliver Sartor, Johann de Bono, et al.
European Urology|September 5, 2024
VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate CancerVeeru Kasivisvanathan, Vinson Wai-Shun Chan, Keiran D Clement, et al.
European Urology|August 25, 2024
Prostate Cancer Early Detection in the European Union and UKRenée C A Leenen, Lionne D F Venderbos, Jozien Helleman, et al.
European Urology|August 25, 2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient SelectionRoger Li, Patrick J Hensley, Shilpa Gupta, et al.
European Urology|May 29, 2024
Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) TrialPrimo N Lara, Catherine Tangen, Elisabeth I Heath, et al.
European Urology|July 28, 2024
Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: An EAU Guidelines UpdateAndreas Skolarikos, Bhaskar Somani, Andreas Neisius, et al.
European Urology|May 18, 2024
Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate CancerSabine D Brookman-May, Marc Buyse, Stephen J Freedland, et al.
European Urology|September 27, 2023
Uncovering the Changing Treatment Landscape for Low-risk Prostate Cancer in the USA from 2010 to 2020: Insights from the National Cancer Data BaseEdoardo Beatrici, Muhieddine Labban, Benjamin V Stone, et al.
European Urology|September 27, 2023
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass)Viktor Grünwald, Philipp Ivanyi, Stefanie Zschäbitz, et al.
European Urology|September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate CancerDaniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
Pageof 889